Ameriprise Financial Inc. Grows Position in Zoetis Inc. $ZTS

Ameriprise Financial Inc. raised its position in Zoetis Inc. (NYSE:ZTS) by 3.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,292,836 shares of the company’s stock after purchasing an additional 112,843 shares during the quarter. Ameriprise Financial Inc. owned 0.75% of Zoetis worth $485,739,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. North Star Asset Management Inc. boosted its holdings in Zoetis by 4.9% during the 2nd quarter. North Star Asset Management Inc. now owns 1,441 shares of the company’s stock valued at $225,000 after acquiring an additional 67 shares during the period. Bank of Nova Scotia Trust Co. grew its position in Zoetis by 4.6% in the 2nd quarter. Bank of Nova Scotia Trust Co. now owns 1,692 shares of the company’s stock valued at $264,000 after acquiring an additional 74 shares during the last quarter. Summit Place Financial Advisors LLC increased its stake in Zoetis by 0.4% in the third quarter. Summit Place Financial Advisors LLC now owns 19,369 shares of the company’s stock worth $2,834,000 after purchasing an additional 76 shares during the period. First County Bank CT lifted its position in shares of Zoetis by 5.4% during the third quarter. First County Bank CT now owns 1,535 shares of the company’s stock worth $225,000 after purchasing an additional 79 shares during the last quarter. Finally, CWA Asset Management Group LLC lifted its position in shares of Zoetis by 1.1% during the third quarter. CWA Asset Management Group LLC now owns 7,236 shares of the company’s stock worth $1,059,000 after purchasing an additional 80 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on ZTS shares. Bank of America upped their price target on shares of Zoetis from $135.00 to $140.00 and gave the stock a “neutral” rating in a report on Friday, February 13th. Leerink Partners reiterated a “market perform” rating on shares of Zoetis in a report on Tuesday, March 10th. Morgan Stanley set a $160.00 price objective on shares of Zoetis in a research report on Thursday, December 18th. Wall Street Zen upgraded shares of Zoetis from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Finally, BTIG Research reaffirmed a “buy” rating and set a $160.00 target price on shares of Zoetis in a research report on Thursday, February 26th. Six research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $152.91.

Zoetis Price Performance

ZTS opened at $115.62 on Monday. The company has a market capitalization of $48.81 billion, a price-to-earnings ratio of 19.21, a PEG ratio of 1.76 and a beta of 0.95. The company has a current ratio of 3.03, a quick ratio of 1.94 and a debt-to-equity ratio of 2.71. Zoetis Inc. has a 12-month low of $114.47 and a 12-month high of $172.23. The business’s fifty day simple moving average is $125.34 and its 200-day simple moving average is $131.58.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The firm had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.36 billion. During the same period in the previous year, the company posted $1.40 earnings per share. The firm’s quarterly revenue was up 3.0% on a year-over-year basis. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, equities research analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 1.8%. Zoetis’s payout ratio is currently 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.